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Abstract
Background: To determine the acute effects of ingesting a thermogenic drink (Celsius, Delray
Beach, FL) (TD) on changes in metabolism and lipolysis.
Methods: Healthy college-aged male (23.2 ± 4.0 y, 177.2 ± 6.1 cm, 81.7 ± 11.3 kg, 22.8 ± 7.3 %
fat; n = 30) and female (23.4 ± 3.1 y, 165.6 ± 8.7 cm, 62.1 ± 9.9 kg, 28.3 ± 7.4 % fat; n = 30)
participants were matched according to height and weight to consume 336 ml of the TD or a non-
caloric, non-caffeinated placebo (PLA). After a 12 h fast, participants reported for pre-consumption
measures of height, weight, heart rate, blood pressure, resting energy expenditure (REE),
respiratory exchange ratio (RER), glycerol and free-fatty acid (FFA) concentrations. REE and RER
were determined at 60, 120, and 180 min post-consumption. Serum glycerol and FFA
concentrations were determined at 30, 60, 120 and 180 min post-consumption.
Results: When compared to PLA, TD significantly increased REE at 60, 120 and 180 min (p < 0.05).
FFA concentrations were significantly greater in TD compared to PLA at 30, 60, 120 and 180 min
post-consumption (p < 0.05). No between-group differences were found in RER.
Conclusion: Acute TD ingestion significantly increased REE, FFA and glycerol appearance. If
sustained, these changes may help to promote weight loss and improve body composition;
however, these findings are currently unknown as are the general safety and efficacy of prolonged
consumption.
Background
The prevalence of individuals who are classified as over-
weight and obese is a primary health concern due to their
relationship to various cardiovascular diseases [1,2] and
associated comorbidities [1]. Recent epidemiological data
suggests that 31% of the United States (U.S.) population
is classified as obese, according to body mass index (BMI)
standards, while 65% is classified as overweight [3]. Med-
ical expenses for obesity treatment and its related comor-
bities in 1998 accounted for 9.1% of total medical
expenditures and was reported to be $78.5 billion, which
would exceed $100 billion in today's economy [4]. In
addition to reducing medical costs, weight loss can reduce
risk for cardiovascular disease, improve quality of life and
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ease the economic burden due to missed work and dimin-
ished work productivity [2,5,6]. Weight loss can be
achieved by maintaining a proper diet and or starting an
exercise regime; however, adherence to conventional
weight-loss programs has been poor [3]. As a result the use
of nutritional supplements to aid weight loss has
increased in popularity, with consumers spending an esti-
mated $37.1 billion per year [7].
Many consumers are turning to thermogenic drinks as a
means to increase calorie and fat burning, energy levels
and weight loss. While the number of TD has increased in
recent years, they typically contain a mixture of caffeine,
catechins, various herbal extracts, amino acids, neuros-
timulants and vitamins. Ingredients in these products
have been shown to increase metabolism [8-13], decrease
body fat [14,15] and increase markers of lipolysis [14,16-
19]. Furthermore, recent work has affirmed that a TD con-
taining caffeine, citrus aurantium, garcinia, cambogia and
chromium polynicotinate to increase calorie expenditure
[13,20]. However, limited research has been reported on
the impact of ingesting a TD in either an acute or pro-
longed fashion on energy expenditure and circulating
markers of lipolysis. Furthermore, the potential for a TD
to promote acute increases in fat metabolism appear
promising as a recently published study reported a TD
containing tyrosine, capsaicin, catechins and caffeine
increased resting metabolism 4 hours post consumption
compared to a placebo drink [21]. Therefore, the purpose
of this study was to examine the acute effects of ingesting
a commercially available TD (Celsius, Celsius, Inc., Delray
Beach, FL) for changes in resting energy expenditure (REE)
and serum markers of lipolysis. It was hypothesized that
acute TD ingestion would increase resting energy expend-




Healthy college-aged males (n = 30) and females (n = 30)
participated in this study (Table 1). All testing was con-
ducted after the participant signed the IRB-approved
informed consent and completed comprehensive medical
history questionnaires. Participants were excluded if they:
1) had a history of hypertension, metabolic, hepatorenal,
musculoskeletal, autoimmune or neurological disease; 2)
were currently taking thyroid, antihyperlipidemic,
hypoglycemic, anti-hypertensive or androgenic medica-
tions; or 3) had consumed nutritional supplements that
may affect metabolism [i.e., over 100 mg·d-1 of caffeine,
ephedrine alkaloids, guggulsterones, etc.] and/or muscle
mass [i.e. creatine, protein/amino acids, androstenedione,
dihydroepiandrosterone (DHEA), etc.] within three
months of starting the study.
Experimental design
Participants reported to the laboratory for a single testing
session following completion of a 2-day food diary, a 12
h overnight fast and 24 h avoidance of exercise. Upon
arrival, participants were matched into clusters according
to age and fat free mass and distributed evenly among
both groups. Participants were then assigned in a single-
blind fashion to ingest in a daily fashion isovolumetric
amounts (336 ml) of either the thermogenic drink (TD)
or placebo (PLA). The PLA drink was a commercially
available carbonated, non-caloric, non-caffeinated bever-
age. Measures of body mass, height, blood pressure, heart
rate, percent body fat, REE, glycerol and free fatty acids
were obtained.
Anthropometric measures
After voiding, participants changed into minimal clothing
and were barefoot for measurement of body mass and
height on a calibrated scale and standiometer (Detecto,
Webb City, MO). Body mass and height were measured to
the nearest 0.05 kg and 0.5 cm, respectively. For measure-
ment of height participants were instructed to stand erect,
inhale deeply, point toes up and look straight ahead. After
resting for 5 min, heart rate and blood pressure were
obtained according to standard procedures using an auto-
mated blood pressure monitor (Omron HealthCare, Inc.,
HEM-757, Vernon Hills, IL). Omron HealthCare, Inc.
reports the HEM-757 to have a standard deviation of ± 3
mmHg for blood pressure and to be within ± 5% of pulse
rate.
Body composition
Measures of percent body fat were obtained using a BOD
POD® (Life Measurement, Inc., Concord, CA). Prior to
each test the BOD POD® was calibrated according to the
manufacturer's instructions. Participants then changed
into a tight fitting bathing suit and swim cap before sitting
in the BOD POD®. The BOD POD® was then sealed while
the subject sat motionless and breathed normally for 20
sec while body volume was measured. Thoracic gas vol-
ume correction was performed according to standard pro-
cedures. Our lab has previously demonstrated total error
of measurement values of 0.66% body fat.
Table 1: Subject demographics
Variable TD (n = 30) PLA (n = 30) Significance
Age (y) 23.3 ± 0.6 23.3 ± 0.7 1.00
Height (cm) 172.1 ± 1.8 170.7 ± 1.6 0.56
Body mass (kg) 72.6 ± 2.6 71.2 ± 2.7 0.71
Systolic BP (mm Hg) 124 ± 2 121 ± 3 0.51
Diastolic BP (mm Hg) 78 ± 2 77 ± 2 0.49
Heart Rate (beats·min-1) 71 ± 3 72 ± 2 0.77
TD, Thermogenic drink; PLA, placebo. Values are expressed as means 
± SE.Journal of the International Society of Sports Nutrition 2008, 5:6 http://www.jissn.com/content/5/1/6
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Resting energy expenditure and respiratory exchange ratio
Resting energy expenditure was determined to assess
changes in whole body energy expenditure after drink
ingestion. Participants were led to a quiet, dark, thermally
controlled room and were instructed to lie in a supine
position. A clear, hard plastic breathing hood with a clear
plastic drape was attached to a metabolic cart (ParvoMed-
ics TrueOne® 2400, Sandy, UT) and placed over the partic-
ipants head and upper torso. Mean oxygen uptake (VO2)
and carbon dioxide output (VCO2) were measured for
each breath and averaged over 15 sec intervals. REE and
RER were measured for 20 minutes and reported data rep-
resent a 5 min window at the end of the collection period
in which a criterion variable (VO2) deviated by less than
5%. Test-retest correlations (r) using this device were in
the range of 0.550 – 0.747 with a mean intra-class coeffi-
cient of 0.893, p < 0.001.
Venous blood sampling
Venous blood samples were taken from an antecubital
vein using standard phlebotomy techniques with a 22-
gauge needle and a 6 mL serum separation vacutainer tube
(BD Vacutainer®, Franklin Lakes, NJ). Each vacutainer was
inverted several times and immediately centrifuged at
3,500 rpm for 15 min. The resulting supernatant was then
aliquoted into two microcentrifuge tubes and stored at -
20°C for subsequent analysis.
Glycerol and free fatty acid analyses
To assess acute changes in serum levels of lipolysis, serum
concentrations of glycerol and FFAs were determined in
duplicate. Glycerol was assessed using a calibrated com-
mercial oxidase enzyme reaction analyzer and reagents
(Analox GM7, Analox Instruments, London, England).
FFAs were assessed using a commercial colorimetric assay
(Roche, Penzeberg, Germany) and read with a spectro-
photometer (SmartSpec™Plus, Bio-Rad, Hercules, CA) at a
wavelength of 546 nm. Assay precision (coefficient of var-
iation (CV)) and accuracy (percent of un-recovery) were
calculated using control samples for glycerol and FFAs by
8 replicate determinations. The reported CV and percent of
un-recovery for glycerol (240 μM control serum: 2.5%,
1.2%) and free fatty acid control serums (0.35 mM con-
trol serum: 8.9%, 3.6%) were found to be within accepta-
ble ranges [22,23].
Statistical analysis
Separate two-way (group × time) repeated measures ANO-
VAs on raw data were first used to determine differences
between genders, testing sessions, and interactions. Delta
values (testing point – baseline) were calculated for rela-
tive REE, glycerol content, free fatty acid content and are
displayed in all figures. When necessary, additional one-
way ANOVAs were used to further evaluate any significant
group × time interactions. Baseline demographic, body
composition and dietary intake data were analyzed using
independent t-tests. When the sphericity assumption was
not met, the conservative Hunyh-Feldt Epsilon correction
factor was used to evaluate observed within-group F
ratios. A probability level of ≤ 0.05 was to determine sig-
nificance.
Results
Subject demographics and nutritional data
No baseline significant differences were found between
age, height, weight, body composition (Table 1). Addi-
tionally, no statistical differences between groups were
found for caloric intake (TD: 25.78 ± 8.49 vs. PLA: 29.15
± 13.29 kcal·kg·d-1; p = 0.21), protein (TD: 1.16 ± 0.44
vs. PLA: 1.27 ± 0.78 g·kg·d-1; p = 0.50), carbohydrate
(TD: 3.27 ± 1.16 vs. PLA: 3.73 ± 1.67 g·kg·d-1; p = 0.23)
or fat (TD: 0.91 ± 0.39 vs. PLA: 1.07 ± 0.60 g·kg·d-1; p =
0.23) intake.
Acute changes in REE and RER
A significant group × time interaction (p = 0.004) was
found for relative REE (Figure 1). No main effect for group
was found while additional one-way ANOVAs revealed
significant between group differences for delta change in
relative REE at 60 (p = 0.005), 120 (p = 0.009) and 180 (p
= 0.005) min. Additionally, a significant group × time
interaction (p = 0.004) was found for the raw REE
(kcals·d-1) data in addition to a main effect for time (p <
0.001; Table 2). However, no main effect for group was
found (p = 0.089). No significant group × time interaction
was found for RER; however, a significant main effect for
time (p < 0.001) was found (Table 2).
Acute glycerol and FFA levels
A significant group × time interaction (p = 0.001) was
found for FFA (Figure 2) while no such changes was found
in serum glycerol levels (p = 0.18; Figure 3). Significant
main effects for time were found for changes in FFA (p <
0.001) and glycerol (p < 0.001), revealing similar
increases in both groups across time. One-way ANOVAs
revealed significantly higher levels of circulating FFA at 30
(p = 0.001), 60 (p < 0.001), 120 (p < 0.001) and 180 min
(p = 0.03) following CEL ingestion when compared to
PLA. Additional one-way ANOVAs revealed a trend
toward significantly higher levels of circulating glycerol at
30 min (p = 0.054) following CEL ingestion compared to
PLA with no other reported changes.
Discussion
The purpose of this study examined the acute effects of
ingesting a commercially available thermogenic drink
(TD) on energy expenditure and lipolysis independent of
diet and/or exercise modifications. Upon considering pre-
vious animal and human research, we hypothesized that
energy expenditure, fat oxidation and serum levels ofJournal of the International Society of Sports Nutrition 2008, 5:6 http://www.jissn.com/content/5/1/6
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lipolysis markers would acutely increase after ingestion.
Of the active ingredients, caffeine and epigallocatechin
gallate (EGCG, an abundant catechin in green tea) [24]
are the most common and have been found to increase
energy expenditure [8,10,11,25-29] and increase markers
of lipolysis [8-11]. In this regard, caffeine increases energy
metabolism through stimulation of β-adrenergic recep-
tors and adenyl cyclase resulting in activation of cyclic
AMP (cAMP), causing subsequent increases in circulating
epinephrine [30,31] and free fatty acids [32]. Caffeine
may also enhance lipolysis by inhibiting nucleotide phos-
phodiesterase resulting in increased tissue concentrations
of cAMP and activation of hormone-sensitive lipase,
which provides further explanation for the increased cir-
culating levels of free fatty acids seen in the present study
[12]. In this regard, caffeine doses of 6 mg·kg-1 in individ-
uals with impaired epinephrine responses have been
shown to increase FFA and glycerol concentration inde-
pendent of a significant change in epinephrine [33]. An
additional bioactive ingredient of importance is the green
tea catechin, EGCG. Recent human and animal investiga-
tions have demonstrated various positive health effects of
EGCG administration. For example, Boschmann gave 300
mg·d-1 of EGCG alone to six obese men and measured
energy expenditure and respiratory quotient changes [34].
While overall energy expenditure did not change, the res-
piratory quotient numbers did lower in response to EGCG
administration leading the authors to conclude that
EGCG alone may be beneficial to increase fat oxidation,
although no biochemical measures of fat oxidation were
measured. Furthermore, Hill and colleagues reported an
improved heart rate and glycemic response in obese, post-
menopausal women after 12 weeks of EGCG consump-
tion (150 mg·d-1) along with a walking exercise program
[35]. In a more mechanistic fashion, recent studies have
also suggested EGCG may alter food digestibility [15,36]
and downregulate stearoyl-CoA desaturase (SCD1) gene
expression [15], which may reduce adiposity, decrease
lipid synthesis and increase liver fatty acid oxidation, as
was found in SCD1 knockout mice [15,37].
In support of our hypothesis, acute TD consumption sig-
nificantly increased relative REE at 60, 120 and 180 min
post-ingestion when compared to a non-caloric, non-caf-
feinated placebo. When this data was not normalized to
body mass (kcals·d-1) and expressed relative to baseline
levels, the TD group burned an average of 106 more calo-
ries when compared to PLC over the 3 h testing period
(data not shown). When expressed as a percent increase
from baseline, calorie burning in the TD group was
increased by an average of 10.45% whereby calorie burn-
ing in the PLC group was only 0.89% (data not shown).
In accordance with these findings, Rudelle et al. (2007)
reported a 4.6% increase of energy expenditure 24 h after
ingesting a thermogenic drink containing similar ingredi-
ents ([38]. Further, single 100 mg doses of caffeine have
been shown to increase metabolic rate 3–4%, while a
titrated dosing pattern of 6 × 100 mg over a 12 h period
may increase energy expenditure 8–12% [10]. Similar
changes to these were found in the present study and are
likely due to the combination of caffeine and EGCG pro-
Delta changes in relative REE (kcal·kg-1·d-1) Figure 1
Delta changes in relative REE (kcal·kg-1·d-1). Data is 
expressed as means ± SE. † TD greater than baseline (p < 
0.05). § PLA greater than baseline (p < 0.05). * TD > PLA (p 
< 0.05). TD, thermogenic drink (n = 30); PLA, placebo (n = 
30).
Table 2: Energy expenditure data
Variable Time PLA (n = 30) TD (n = 30) Significance
RER Pre 0.83 ± 0.08 0.81 ± 0.08 Group 0.870
60 min 0.82 ± 0.09 0.81 ± 0.10 Time < 0.001*
120 min 0.79 ± 0.07 0.80 ± 0.07 G × T < 0.860
180 min 0.78 ± 0.07 0.78 ± 0.11
REE (kcals·d-1) Pre 1581 ± 337 1636 ± 307§ Group ± 0.090
60 min 1641 ± 325 1782 ± 278§ Time < 0.001*
120 min 1632 ± 295 1801 ± 283§ G × T ± 0.004§
180 min 1639 ± 325 1802 ± 296§
TD, thermogenic drink; PLA, placebo; Data are means ± SE.
* Significant main effect for time (p < 0.05).
§ TD > PLA (p < 0.05).Journal of the International Society of Sports Nutrition 2008, 5:6 http://www.jissn.com/content/5/1/6
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vided by the energy drink. In a contrasting fashion, sub-
strate oxidation was hypothesized to change following TD
ingestion as prior research has found caffeine to positively
increase FFA concentrations [8,28,39,40] and fat oxida-
tion [8,9,11,28]. In support of this research, FFA concen-
trations from the present study were significantly greater
following TD consumption compared to PLA at 30, 60,
120 and 180 min post-ingestion (Figure 3). Increased FFA
concentrations in the TD group are likely explained by the
stimulatory effects of caffeine on circulating epinephrine
[41] and subsequent downstream activation of lipolysis
by way of the β-adrenergic receptors.
From a biochemical perspective, changes in serum con-
centrations of glycerol were not as prominent as FFA con-
centrations. These results, however, are consistent with
prior research which has found FFA concentrations to be
significantly elevated up to 180 min post-ingestion while
glycerol values were only significantly elevated 60 min
post-ingestion [37]. Another study found FFA concentra-
tions to be significantly elevated 60 min post-ingestion
with a trend toward increased glycerol concentrations 60
min post-ingestion. There were no changes in glycerol
release from skeletal muscle in participants consuming
caffeine suggesting fat oxidation was not enhanced in
skeletal muscle [42] and that a tissue-specific lipolytic
response may impact overall serum concentrations. It has
been hypothesized that increased glycerol concentrations
following caffeine ingestion are most likely a function
adenosine-receptor antagonism, resulting in glycerol
release from adipose tissue [37].
The results of this study suggest that the proprietary ther-
mogenic blend contained in the TD may be an effective
stimulus to promote weight loss independent of modifi-
cations in diet or exercise, as TD consumption increased
REE, calorie burning and circulating levels of FFA. Due to
the acute nature of this study, however, it is not known if
the proprietary blend contained in this TD is effective at
decreasing body fat as the effects of the ingredients may
diminish with chronic use. As a result more prolonged
studies should seek to examine the impact of daily TD
ingestion with or without diet and exercise changes to
determine changes in body mass as well as body compo-
sition along with markers of lipolysis and metabolism.
Conclusion
Acute TD ingestion appears to stimulate significant
increases in energy expenditure and circulating levels of
FFA while substrate oxidation and circulating levels of
glycerol experienced non-significant decreases across
time. Additional research needs to further examine the
impact of prolonged daily ingestion of TD on energy
expenditure, changes in body composition and efficacy of
daily ingestion of TD. These studies will provide addi-
tional evidence for any role TD may play at promoting
weight loss and/or achieving weight maintenance.
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